Quality of Life in Patients With Hypoparathyroidism After Treatment for Thyroid Cancer
Matthias Büttner(Johannes Gutenberg University Mainz), Susanne Singer(Rostock University of Music and Theatre), E Vidhubala(Tirunelveli Medical College), Juan Ignacio Arrarás, Laura D. Locati(University of Pavia), Georgios Ioannidis(Nicosia General Hospital), Iwona M. Tomaszewska(Jagiellonian University), Naomi Kiyota(Kobe University Hospital), Guy Andry(Institut Jules Bordet), Dina Salem(Ain Shams University), Olga Husson(Erasmus MC), Juliane Theurer(Johannes Gutenberg University Mainz), Eva Hammerlid(Sahlgrenska University Hospital), Christine Brannan(Mount Vernon Cancer Centre), Eva‐Maria Gamper(Innsbruck Medical University), Johanna Inhestern, Kathy Taylor(Johannes Gutenberg University Mainz), Cláudia Araújo(IPO Porto), Monica Pinto(Jagiellonian University)
Cited by 54
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study.
|Journal of Clinical Oncology|1996|1.2k
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
|Oral Oncology|2018|802
The development of the EORTC QLQ-C15-PAL: A shortened questionnaire for cancer patients in palliative care
|European Journal of Cancer|2005|687